Poultry Vaccines Global Market 2024 - Growth Opportunities, Top Countries, Future Trends, Revenue And Outlook 2033

The Business Research Company recently released a comprehensive report on the Global Poultry Vaccines Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.

Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=8622&type=smp

According to The Business Research Company's, The poultry vaccines market size has grown strongly in recent years. It will grow from $1.64 billion in 2023 to $1.8 billion in 2024 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to epidemic outbreaks, globalization of poultry trade, shifts in consumer demand, environmental concerns, emerging infectious diseases, focus on antibiotic alternatives.

The poultry vaccines market size is expected to see strong growth in the next few years. It will grow to $2.59 billion in 2028 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to disease mutation and evolution, global expansion of poultry industry, increasing demand for protein-rich foods, environmental concerns and sustainability, rising focus on animal welfare. Major trends in the forecast period include digitalization in vaccination management, focus on antibiotic alternatives, advanced production efficiency, emerging infectious diseases, environmental concerns.

Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/poultry-vaccines-global-market-report

Market Drivers and Trends:

The increasing prevalence of zoonotic diseases is expected to propel the growth of the poultry vaccine market going forward. Zoonotic diseases are a group of common diseases caused by pathogenic germs such as viruses, bacteria, parasites, and fungi. The significant changes in land use, and increased urbanization have all been linked to disease onset by increasing human-animal encounters and quickening transmission rates, climate change, urbanization, and the degradation of natural habitats raise the danger of zoonotic illnesses. Due to the surge in the number of zoonotic cases, there is an increase in demand for poultry vaccines. For instance, in July 2022, according to an article published by the World Health Organization, a US-based government agency, there was a 64% rise in the number of zoonotic cases in Africa. Furthermore, zoonotic illnesses are on the increase both internationally and in India. These emerging infectious diseases in humans account for 60% of cases, with 816 zoonotic pathogens out of 1407 human pathogens. Therefore, the increasing prevalence of zoonotic diseases is expected to drive the growth of poultry vaccines.

Technological advancements in poultry vaccines are a key trend gaining popularity in the poultry vaccines market. Innovation and technologies have resulted in vaccines becoming the most effective and cost-effective illness prevention measures for poultry animals. Major companies operating in the poultry vaccine market are focused on developing new technological solutions to strengthen their position. For instance, in October 2023, Zoetis Inc. a US-based animal health company launched Circomax. The porcine circovirus type 2 (PCV2) vaccine comes in two genotypes a and b. The goal of the vaccination is to defend against PCV2 risks, such as the three genotypes seen in the UK pig herd, and to offer broader coverage. The only PCV2 vaccination that is licensed to protect against all three genotypes is this one, which has shown protection against PCV2a, PCV2b, and PCV2d. With the introduction of CircoMax, Zoetis is attempting to keep ahead of the PCV2 genotype evolution and offer healthy piglets high levels of efficacy, convenience, and proven safety.

Key Benefits for Stakeholders:

• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.

Major Key Players of the Market:

Merck & Co Inc., Boehringer Ingelheim International GmbH, Zoetis Inc., Ringpu Biology, MSD Animal Health, Elanco Animal Health Incorporated, Ceva Santé Animale S.A., Phibro Animal Health Corporation, Huvepharma AD, Venkys India Limited, Vetoquinol S.A., Indian Immunologicals Limited, Vaccination Services Pvt Ltd., Indovax Private Limited, Pharmaq AS, Bio-Vet Inc., Hester Biosciences Limited, Intervet Inc., Anicon Labor GmbH, CZ Veterinaria S.A., Bioproperties Pty Ltd, Torigen Pharmaceuticals Inc., Bioveta a.s., Aptimmune Biologics Inc., HIPRA S.A., Biovac (Pty) Ltd., VerovacciNES Inc., Lohmann Animal Health GmbH & Co KG, Nisseiken Co Ltd., Zydus Animal Health Limited, Jinyu Bio-Technology Co Ltd., Kyoto Biken Laboratories Inc., Phage Technology Inc.

Poultry Vaccines Market 2024 Key Insights:

• The poultry vaccines market size is expected to see strong growth in the next few years. It will grow to $2.59 billion in 2028 at a compound annual growth rate (CAGR) of 9.5%.
• Rising Zoonotic Disease Threats Drive Surging Demand For Poultry Vaccines In Global Markets
• Advancements In Poultry Vaccine Technology Through A Focus Genotype Evolution
• North America was the largest region in the poultry vaccines market in 2023

We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=8622&type=smp

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.